Maintain Bladder Cancer Care During Covid-19 and Beyond

To learn more, we invite you to join a special Virtual Dinner Program on Cxbladder, sponsored by Pacific Edge.

January 13th, 7-8pm Eastern

Cxbladder is an accurate genomic urine test for the detection and management of bladder cancer. With In-Home Sampling and Medicare coverage, Cxbladder is ideally suited to a Covid-19 environment and ongoing care where in-person visits may be challenging or not possible.

To learn more, we invite you to join our Virtual Dinner Program on the January 13th. Our Faculty will be discussing their real-world experience with Cxbladder and use cases where the test can be of benefit to both your patients and your practice.

FACULTY AND TOPICS

SIA DANESHMAND, MD

Professor of Urology (Clinical Scholar)
Director of Urologic Oncology
Director of Clinical Research
Urologic Oncology Fellowship Director
USC/Norris Comprehensive Cancer Center
Los Angeles, CA

MODERATOR

KRISTEN R. SCARPATO, MD, MPH, FACS

Associate Professor of Urology
Urology Residency Program Director and the Vice-Chair of Education
Vanderbilt University Medical Center
Nashville, TN

Presenting:
CXBLADDER OVERVIEW

EVAN R. GOLDFISCHER, MD, MBA, FACS, CPE, CPI

Assistant Professor of Urology
New York Medical College
Director of Research
Premier Medical Group
Hudson Valley, NY

Presenting:
USE IN ADJUDICATING ATYPICAL BLADDER CYTOLOGY

KATIE S. MURRAY, DO, MS, FACS

Assistant Professor of Urology
University of Missouri School of Medicine
Ellis Fischel Cancer Center
Medical Director of Urological Oncology Ellis Fischel Cancer Center
Columbia, Missouri

Presenting:
UTILITY OF IN-HOME SAMPLING CXBLADDER

JOHN P. SFAKIANOS, MD

Assistant Professor, Urologic Oncology
Department of Urology, Icahn School of Medicine at Mount Sinai
New York, NY
Premier Medical Group

Presenting:
UTILITY OF CXBLADDER MONITOR IN SURVEILLANCE

Cxbladder Benefits

Reliable: Cxbladder utilizes high sensitivity and negative predictive value to either help rule out the disease or complement other diagnostic procedures and tests to improve overall detection accuracy.

Clinically proven: Proven performance in over 12 peer-reviewed publications for primary detection, surveillance, and adjudicating atypical cytology. Cxbladder is used by over 2,000 urologists in more than 80,000 patients.

Non-invasive and easy-to-use: Cxbladder’s unique urine sample collection system is discrete, non-invasive and easy-to-use, taking only minutes.

Covered by Medicare: Cxbladder is now covered by Medicare.

In-home sampling: To streamline patient care we are now offering an in-home sampling service to both hematuria and surveillance patients.

Quick: Upon receiving a urine sample, our certified US laboratory will provide actionable results in 7 days.

Download our Clinician Brochure

Tests Optimized for Primary Detection and Surveillance

Cxbladder Detect

In cases where a patient is symptomatic and bladder cancer looks likely, Cxbladder Detect can help confirm your diagnosis. By detecting and quantifying signs of cancer at the molecular level, Cxbladder Detect outperforms other urine-based tests, making it an ideal choice for bladder cancer testing when patients present with significant symptoms. Cxbladder Detect can also be used as an adjunct to cystoscopy or as a substitute for other radiological tests to improve overall detection accuracy.

Cxbladder Monitor

Developed specifically for patients undergoing surveillance for recurrent bladder cancer, Cxbladder Monitor combines clinical information linked to previous bladder cancer with measured biomarker genes to help rule out the presence of a recurrent tumour, or to indicate that further clinical investigation is required.

Cxbladder Monitor can provide accurate results with a single urine sample, and test is often used as a non-invasive monitoring alternative to reduce the frequency of cystoscopy required.

Download our Clinician Brochure

In-Home Sampling is Now Available

Cxbladder’s unique urine sampling system is non-invasive and easy-to-use. The process is quick and painless, taking only minutes.

To simplify and streamline the bladder cancer testing process, we are now offering in-home sampling for both hematuria and surveillance patients. Participating patients have the option of submitting their urine sample in the comfort of their own home without the need to physically visit their Urologist.

Medicare Now Covers Cxbladder

We’re pleased to confirm that Cxbladder is now covered by Medicare.

For questions about coverage please call the Cxbladder Assist Team at 1-855-CXBLADR (1-855-292-5237, option 1).

The Difference in Cancer Detection

Cxbladder is a reliable test for bladder cancer that can help you make informed treatment and care decisions. To learn more, register for our Special Dinner Program and listen to our Faculty discussing their real-world experience with Cxbladder and use cases where the test can be of benefit to both your patients and your practice.